Morten Holmström
0000-0002-3764-8578
Herlev Hospital
2 papers found
Refreshing results…
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation
Missing publications? Search for publications with a matching author name.